ID
25325
Description
Study ID: 101468/191 Clinical Study ID: SKF-101468/191 Study Title:A 12 Week, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Ropinirole in Subjects with Restless Legs Syndrome (RLS) Suffering from Periodic Leg Movements of Sleep (PLMS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication: Restless Legs Syndrome
Keywords
Versions (1)
- 9/1/17 9/1/17 -
Uploaded on
September 1, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
GSK Ropinirole in Subjects with Restless Legs Syndrome 101468/191 Week 8 (Form 13)
GSK Ropinirole in Subjects with Restless Legs Syndrome 101468/191 Week 8 (Form 13)
Description
RLS rating scale
Description
Vital signs
Description
Pulse
Data type
integer
Measurement units
- beats/min
Description
Sitting blood pressure (systolic)
Data type
integer
Description
Sitting blood pressure (diastolic)
Data type
text
Description
Medical Procedures
Data type
text
Description
Concomitant Medication
Data type
text
Description
Adverse Experiences
Data type
text
Description
Ramos Randomization and Dispensing
Data type
integer
Description
Container numbers I
Data type
text
Description
Container numbers II
Data type
text